# INOVIO PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/inovio-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:51.162298+00:00 | | Last reviewed | 2026-10-17T04:46:51.162298+00:00 | ## Identity - Legal name: INOVIO PHARMACEUTICALS, INC. - Display name: INOVIO PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T09:51:57.805811+00:00 | | Completeness | 0.409 | | Record Quality | 0.84 | | Directors | 8 | | Committees | 7 | | Governance events | 20 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ann C. Miller, M.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:5 - David B. Weiner, Ph.D.: Director. Status: current. Independent: false. Since: 2016-01-01. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:6 - Jacqueline E. Shea, Ph.D.: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:7 - Jay P. Shepard: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:8 - Lota S. Zoth: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:9 - Roger D. Dansey, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:10 - Simon X. Benito: Director. Status: current. Independent: true. Since: 2003-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:11 - Wendy L. Yarno: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:12 ## Committees - Audit (audit). Chair: Lota S. Zoth. Members: Lota S. Zoth (chair, current); Jay P. Shepard (member, current); Simon X. Benito (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Lota S. Zoth (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:audit-chair-compensation - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Simon X. Benito (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Jay P. Shepard (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:audit-nominating-and-governance - Compensation (compensation). Chair: Wendy L. Yarno. Members: Wendy L. Yarno (chair, current); Lota S. Zoth (member, current); Simon X. Benito (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:compensation - Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Wendy L. Yarno (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:compensation-chair-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: Simon X. Benito. Members: Simon X. Benito (chair, current); Jay P. Shepard (member, current); Wendy L. Yarno (member, current). committee_id=alpha:committee:inovio-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Jacqueline E. Shea, Ph.D.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:13 - Laurent M. Humeau, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:14 - Michael Sumner, M.D.: Chief Medical Officer and Head of Development. Status: current. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:15 - Peter D. Kies: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:16 ## Governance events - CEO_CHANGED: Jacqueline E. Shea, Ph.D. executive of INOVIO PHARMACEUTICALS, INC., effective 2026-04-07. Effective: 2026-04-07. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:jjgkap1w8yplh - EXECUTIVE_APPOINTED: Laurent M. Humeau, Ph.D. executive of INOVIO PHARMACEUTICALS, INC., effective 2026-04-07. Effective: 2026-04-07. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:31h1qz8blpmx - EXECUTIVE_APPOINTED: Michael Sumner, M.D. executive of INOVIO PHARMACEUTICALS, INC., effective 2026-04-07. Effective: 2026-04-07. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:12zps551xx7ai7 - CFO_CHANGED: Peter D. Kies executive of INOVIO PHARMACEUTICALS, INC., effective 2026-04-07. Effective: 2026-04-07. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1qaxfobg7zuk - DIRECTOR_APPOINTED: Jacqueline E. Shea, Ph.D. seat on INOVIO PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1qsnms11h4oo3 - DIRECTOR_APPOINTED: Roger D. Dansey, M.D. seat on INOVIO PHARMACEUTICALS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1j092vcz5q5xa - DIRECTOR_APPOINTED: Jay P. Shepard seat on INOVIO PHARMACEUTICALS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:f6bkv01ufsdvy - COMMITTEE_CREATED: Audit; Nominating and Governance committee of INOVIO PHARMACEUTICALS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:kuafxwd8633q - COMMITTEE_MEMBER_ADDED: Jay P. Shepard member of Audit; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:2cjkvilnfypu - DIRECTOR_APPOINTED: Ann C. Miller, M.D. seat on INOVIO PHARMACEUTICALS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1k2dyqh3fpqtp - DIRECTOR_APPOINTED: Lota S. Zoth seat on INOVIO PHARMACEUTICALS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:90siz1104ua1t - COMMITTEE_CREATED: Audit · Chair; Compensation committee of INOVIO PHARMACEUTICALS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1vqabz710wblql - COMMITTEE_MEMBER_ADDED: Lota S. Zoth member of Audit · Chair; Compensation, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1lsp8ksfnz7xa - DIRECTOR_APPOINTED: Wendy L. Yarno seat on INOVIO PHARMACEUTICALS, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:alm7zl1j50rvh - COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of INOVIO PHARMACEUTICALS, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1p2s8rz9zrxip - COMMITTEE_MEMBER_ADDED: Wendy L. Yarno member of Compensation · Chair; Nominating and Governance, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:qk8zs2457gek - DIRECTOR_APPOINTED: David B. Weiner, Ph.D. seat on INOVIO PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:omwyj11c4dhdt - DIRECTOR_APPOINTED: Simon X. Benito seat on INOVIO PHARMACEUTICALS, INC., effective 2003-01-01. Effective: 2003-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:7fbjuf44sryr - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of INOVIO PHARMACEUTICALS, INC., effective 2003-01-01. Effective: 2003-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:by13uvx31ykj - COMMITTEE_MEMBER_ADDED: Simon X. Benito member of Audit; Compensation; Nominating and Governance · Chair, effective 2003-01-01. Effective: 2003-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:13roby0xfu5ki ## Scoped resources - `alpha://company/inovio-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record - `alpha://company/inovio-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/inovio-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/inovio-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=board - `alpha://company/inovio-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/inovio-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/inovio-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/inovio-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/inovio-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/inovio-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/inovio-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/inovio-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/inovio-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/inovio-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/inovio-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/inovio-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/inovio-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/inovio-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/inovio-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/inovio-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=events - `alpha://company/inovio-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/inovio-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/inovio-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:lota-s-zoth","name":"Lota S. Zoth"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jay-p-shepard","name":"Jay P. Shepard"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:simon-x-benito","name":"Simon X. Benito"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:wendy-l-yarno","name":"Wendy L. Yarno"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lota-s-zoth","name":"Lota S. Zoth"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:simon-x-benito","name":"Simon X. Benito"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:simon-x-benito","name":"Simon X. Benito"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jay-p-shepard","name":"Jay P. Shepard"},"source_id":"board_seats"}` - Claim alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:wendy-l-yarno","name":"Wendy L. Yarno"},"source_id":"board_seats"}` ## Leadership - Ann C. Miller, M.D.: Director. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - David B. Weiner, Ph.D.: Director. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:6. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Jacqueline E. Shea, Ph.D.: Director. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Jay P. Shepard: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Lota S. Zoth: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Roger D. Dansey, M.D.: Director. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Simon X. Benito: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:11. Valid from: 2003-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Wendy L. Yarno: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:12. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588. - Jacqueline E. Shea, Ph.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:13. Valid from: 2026-04-07. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8f1294f7e46937438027b3cfe480ffb2c6ed0135bd93cc79e537c23f01fedff9. - Laurent M. Humeau, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:14. Valid from: 2026-04-07. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4b6e35f2d5f0e990b07174a46dcbe4b9422ef8f6ae83cd57bc85bb1eca11cb36. - Michael Sumner, M.D.: Chief Medical Officer and Head of Development. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:15. Valid from: 2026-04-07. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5a31bde93476f8a37d8a1cb66aac2b1b2e3aa3a1855d7f789b5dcbbd6d35fe90. - Peter D. Kies: Chief Financial Officer. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:leadership_role:16. Valid from: 2026-04-07. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c24c5ae9b36a12f3ac9677930fba7288f90d4d4134ae372ad980e33a71422925. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Lota S. Zoth; Members Lota S. Zoth (Chair); Jay P. Shepard; Simon X. Benito. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Compensation: Chair Wendy L. Yarno; Members Wendy L. Yarno (Chair); Lota S. Zoth; Simon X. Benito. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Nominating and Governance: Chair Simon X. Benito; Members Simon X. Benito (Chair); Jay P. Shepard; Wendy L. Yarno. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - INOVIO PHARMACEUTICALS, INC.. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d1237644151849e149bdb94c951e8184eb4f41d81617f5a021991e9cbf18596e. ## Entity Status - Public listing published. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d1237644151849e149bdb94c951e8184eb4f41d81617f5a021991e9cbf18596e. ## Published Fact - US. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d1237644151849e149bdb94c951e8184eb4f41d81617f5a021991e9cbf18596e. ## Committee Appointment - Lota S. Zoth: chair, Audit. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Jay P. Shepard: member, Audit. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Simon X. Benito: member, Audit. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Wendy L. Yarno: chair, Compensation. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Lota S. Zoth: member, Compensation. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Simon X. Benito: member, Compensation. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Simon X. Benito: chair, Nominating and Governance. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Jay P. Shepard: member, Nominating and Governance. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. - Wendy L. Yarno: member, Nominating and Governance. Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828. ## Security Listing - INO (NASDAQ). Claim: alpha:claim:company:d662c4ff-5dc9-4fb7-9ed0-803f00adcf65:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d1237644151849e149bdb94c951e8184eb4f41d81617f5a021991e9cbf18596e. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d1237644151849e149bdb94c951e8184eb4f41d81617f5a021991e9cbf18596e: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc). - alpha:projection-evidence:document:f0eccfac42a84b83b40139af5dcc794fe37648530c785fbdb8d50ae0be6e2588: [INOVIO PHARMACEUTICALS, INC. DEF 14A 2026-04-07](https://www.sec.gov/Archives/edgar/data/1055726/000105572626000011/ino-20260407.htm). - alpha:projection-evidence:document:8f1294f7e46937438027b3cfe480ffb2c6ed0135bd93cc79e537c23f01fedff9: [INO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1055726/000105572626000011/ino-20260407.htm). - alpha:projection-evidence:document:4b6e35f2d5f0e990b07174a46dcbe4b9422ef8f6ae83cd57bc85bb1eca11cb36: [INO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1055726/000105572626000011/ino-20260407.htm). - alpha:projection-evidence:document:5a31bde93476f8a37d8a1cb66aac2b1b2e3aa3a1855d7f789b5dcbbd6d35fe90: [INO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1055726/000105572626000011/ino-20260407.htm). - alpha:projection-evidence:document:c24c5ae9b36a12f3ac9677930fba7288f90d4d4134ae372ad980e33a71422925: [INO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1055726/000105572626000011/ino-20260407.htm). - alpha:projection-evidence:49bffa3a227808467bce3393213322adb6e65005d15e4f30c646bda440e27828: [Audit](https://www.sec.gov/Archives/edgar/data/1055726/000105572626000011/ino-20260407.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/inovio-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/inovio-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/inovio-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/inovio-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T09:51:57.611221+00:00; recorded 2026-10-17T09:51:57.611221+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.